Literature DB >> 30290058

An in vitro and in vivo study of the role of long non-coding RNA-HOST2 in the proliferation, migration, and invasion of human glioma cells.

Qi Wang1, Zhong-Wei Zhuang1, Yi-Ming Cheng1, Ji-Qiang Ma1, Shi-Yi Xu1, Chun-Long Zhong1, Kui-Ming Zhang1.   

Abstract

Gliomas are the most commonly occurring primary malignant brain tumors in the central nervous system of adults. They are rarely curable and the prognosis for high grade gliomas is generally poor. Recently, long non-coding RNA (lncRNA) human ovarian cancer-specific transcript 2 (HOST2) has been reported to be expressed at high levels in human ovarian cancer, involving tumorigenesis. However, little is still known about whether and how HOST2 regulates glioma development and progression. Therefore, this study aims to investigate the role of HOST2 in human glioma cells. Reverse transcription quantitative real-time polymerase chain reaction (RT-qPCR) was used to determine the expression of lncRNA HOST2, let-7b, and PBX3 in human glioma cells. Cultured human glioma cells were treated with siRNA (si)-lncRNA HOST2, let-7b mimic, si-lncRNA HOST2 + let-7b inhibitor, and si-PBX3. Parameters including cell viability, colony formation, cell migration, and cell invasion were detected by cell counting kit-8 assay, colony formation assay, scratch test, and Transwell assay respectively to determine the effects of down-regulated HOST2 on glioma cells. Tumor formation in nude mice was evaluated by subcutaneous tumor formation experiment. Results showed that HOST2 and PBX3 were highly expressed in glioma tissue whereas let-7b was expressed at much lower levels. In response to treatment with si-lncRNA HOST2, si-PBX3, and let-7b mimic, glioma cell lines exhibited decreased cell viability, suppressed cell migration, invasion, and reduced colony formation of glioma cells. This was accompanied by an attenuated tumor formation with smaller volume and weight in nude mice, suggesting that down-regulated HOST2 could inhibit the tumorigenicity of glioma cells. Lastly, we found that lncRNA HOST2 was highly expressed in glioma tissues and its down-regulation could inhibit the growth and invasion of glioma cells.
© 2018 IUBMB Life, 71(1):93-104, 2019. © 2018 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  cell invasion; cell migration; cell proliferation; clone formation; glioma; long non-coding RNA HOST2

Year:  2018        PMID: 30290058     DOI: 10.1002/iub.1943

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  5 in total

1.  Long intergenic non-protein coding RNA 00475 silencing acts as a tumor suppressor in glioma under hypoxic condition by impairing microRNA-449b-5p-dependent AGAP2 up-regulation.

Authors:  Lei Yu; Si Gui; Yawei Liu; Xiaoyu Qiu; Binghui Qiu; Xi'an Zhang; Jun Pan; Jun Fan; Songtao Qi; Guozhong Zhang
Journal:  Ther Adv Med Oncol       Date:  2020-08-11       Impact factor: 8.168

2.  Propofol inhibits proliferation, migration, invasion and promotes apoptosis by regulating HOST2/JAK2/STAT3 signaling pathway in ovarian cancer cells.

Authors:  Xiang Shen; Diaolan Wang; Xu Chen; Jun Peng
Journal:  Cytotechnology       Date:  2021-03-24       Impact factor: 2.058

3.  Long noncoding RNA HOST2, working as a competitive endogenous RNA, promotes STAT3-mediated cell proliferation and migration via decoying of let-7b in triple-negative breast cancer.

Authors:  Kaiyao Hua; Xiaochong Deng; Jiashu Hu; Changle Ji; Yunhe Yu; Jiayi Li; Xuehui Wang; Lin Fang
Journal:  J Exp Clin Cancer Res       Date:  2020-04-05

Review 4.  The regulation of PBXs and their emerging role in cancer.

Authors:  Ying Liu; Xiang Ao; Xuehao Zhou; Chengcheng Du; Shouxiang Kuang
Journal:  J Cell Mol Med       Date:  2022-01-23       Impact factor: 5.310

5.  Inhibition of microRNA let-7b expression by KDM2B promotes cancer progression by targeting EZH2 in ovarian cancer.

Authors:  Yan Kuang; Hong Xu; Fangfang Lu; Jiahua Meng; Yeye Yi; Huilan Yang; Hairui Hou; Hao Wei; Shanheng Su
Journal:  Cancer Sci       Date:  2020-11-21       Impact factor: 6.518

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.